Niharith Pharma Private Limited - Due diligence report

A 360° intelligence report on Niharith Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2020-03-19 Dehradun, Uttarakhand Active Unlisted
Share
Connect MCP
NP Niharith Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Niharith Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
79/100
Trust Score
Low Risk

Niharith Pharma Private Limited is assessed as Low Risk with a Trust Score of 79/100. Niharith Pharma Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 12 Aug 2026 from the latest processed filings. Niharith Pharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
79/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (35.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Sidbi1 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2020 - filings overdue.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SARITA TIWARI 01234567 Director 01/04/2018 6 yrs Approved
GIRIJA SHANKAR TIWARI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 35.00 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view48/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 8 events
19 Jul 2021
Director appointed
SARITA TIWARI (Director)
Director ceased
JAI PRAKASH MISHRA
31 Dec 2020
Last AGM held
Annual general meeting
15 Sep 2020
Charge created
Sidbi - 35.00 Lakh
09 Sep 2020
Securities allotted
400000 Equity Shares Without Differential Rights - 40.00 Lakh raised
31 Mar 2020
Latest balance sheet
Filed with ROC
19 Mar 2020
Incorporated
Registered with Roc Uttarakhand
Director appointed
GIRIJA SHANKAR TIWARI (Director)
10

Key Observations

Auto-generated from the data above
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Divine Ayurvedic Heritage Private Limited U24233KL1999PTC012928 Pathanamthitta, Kerala, India
Eustacia Pharmaceuticals Private Limited U51909AP2016PTC103081 Narigapalli, Andhra Pradesh, India
Alliant Specialty Chemicals Private Limited U24304MH2018PTC420163 Mumbai, Maharashtra, India
Athena Zinc Compounds Private Limited U24114TZ1991PTC003395 Coimbatore, Tamil Nadu, India
Homeo House (India) P Ltd U24230MH1994PTC079046 Mumbai, Maharashtra, India
Rupha Lab Sccience Core Private Limited U24110TG2006PTC049046 Hyderabad, Telangana, India
Fort Homeo Pharmacy Private Limited U24239MH1994PTC077816 Mumbai, Maharashtra, India
Shukla Industries Private Limited U24100GJ2011PTC067348 Vadodara, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Niharith Pharma Private Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Niharith Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Niharith Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 79/100, distress signals and MSME payment-delay disclosures - know whether Niharith Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Niharith Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Niharith Pharma Private Limited an active company?

Niharith Pharma Private Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Niharith Pharma Private Limited financially healthy?

Niharith Pharma Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Niharith Pharma Private Limited?

Its overall Trust Score is 79/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Niharith Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Niharith Pharma Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Niharith Pharma Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Niharith Pharma Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.